Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

Autor: Kim Yu, Kim Jin, Min Yoo, HyunYoon Dok, Shin Ho-Jin, Mun Yeung-Chul, Park Yong, Do Young, Jeong Seong, Park Joon, Oh Sung, Lee Suee, Park Eun, Jang Joung-Soon, Lee Won-Sik, Lee Hwe-Won, Eom HyeonSeok, Ahn Jae-sook, Jeong Jae-Heon, Baek Sun, Kim Seok, Kim Won, Suh Cheolwon

Publikováno v: Journal of Hematology & Oncology, Vol 5, Iss 1, p 49 (2012)

Abstract Background The objective of this study was to identify prognostic factors for survival in patients with primary diffuse large B-cell lymphoma (DLBCL) of the adrenal gland. Methods Thirty one patients diagnosed with primary adrenal DLBCL from

Externí odkaz: https://doaj.org/article/47128e2b8d48443d8eba1daf36384a6e

Hidden in Plain Sight: A Case Series of Inflammatory Bowel Disease With Dermatologic Lesions As Initial or Concurrent Manifestations.

Autor: Obeidat K; Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, USA., Salim H; Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, USA., Malone JC; Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, USA., Lee HW; Department of Internal Medicine, University of Texas Medical Branch at Galveston, Galveston, USA., Merwat S; Department of Gastroenterology and Hepatology, University of Texas Medical Branch at Galveston, Galveston, USA.

Publikováno v: Cureus [Cureus] 2024 Mar 05; Vol. 16 (3), pp. e55548. Date of Electronic Publication: 2024 Mar 05 (Print Publication: 2024).